Global Molecular Diagnostics Market & Future Forecast 2010 - 2014

Renub Researchwww.renub.com

Publisher: Renub ResearchPublished: July, 2011

© Renub Research Page 2 of 10

Global Molecular Diagnostics - Market Overview

The global molecular diagnostics market is witnessing a period of profound growth. The

growth is coming from different regions and markets. The various application and

technological sub-segments of molecular diagnostics are also giving the market a big push.

The increase in the aging population and incidences of various chronic diseases are driving the

demand of molecular diagnostics world over. The industry is getting a push from every side

and many factors collectively are fuelling the growth in this industry.

Molecular diagnostics is a vital and dynamic field in which yesterday’s new technologies and

platforms are today becoming populated with novel, diverse, and useful content. Growing

with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 15

Billion by 2014.The fastest growing segment is infectious disease with 21% market share as the

dominant segment. The next fastest growing segment is oncology testing due to rising cases of

cancer patients .The future growth is expected to come from genetic testing, blood screening

testing and neurological testing.

Geographically, the US and EMEA markets are the most advanced in terms of adoption of

molecular testing and make up the majority of the existing market. However, Japanese

molecular diagnostics market is promising with the ageing population and a declining birth

rate is putting the whole Japanese healthcare system under pressure. Under such

circumstances, the role of preventive medical care is increasingly important. China and India

molecular diagnostics market is one of the lucrative markets to rollout the diagnosis business.

As with the rapid advancement Chinese and Indian economy has dramatically increased the

purchasing power of a growing segment of the populace, which coupled with an emerging

mindset toward wellness, preventive medicine, and access to cutting-edge products and

services and makes the future outlook extremely positive for this very exciting new field in

clinical care. The provision of new and cutting-edge molecular tests will surely be followed by

greater affordability as prices come down due to return on investment, competition, and

technology advancement.

© Renub Research Page 3 of 10

Report Details

“Global Molecular Diagnostics Market & Future Forecast 2010 - 2014” report published by

Renub Research provides an in-depth analysis of the past, present and future prospects. The

report has been researched at source globally and features latest available data covering:

Global Molecular Diagnostics Market (2008 to 2014)

Top 8 application wise molecular diagnostics (Infectious Disease Testing, Blood

Screening Testing, Oncology Testing, Genetic Testing, Tissue Typing Testing,

Cardiovascular Disease Testing, Neurological Testing and Food Pathogen Detection

Testing) data of Past, Present and Future Market (2008 to 2014)

Top 7 technological wise molecular diagnostics (PCR based tests, PCR related

technologies, Non-PCR tests, FISH & Innovation testing, Biochips, Biosensor & Other

technologies) data of Past, Present and Future Market (2008 to 2014)

Top 9 Countries (USA, Europe the Middle East & Africa , Japan, China, India, Germany,

Brazil, Mexico and South Korea) data of Past, Present and Future Market

Mergers and Acquisitions in the molecular diagnostics market

Key drivers of growth in the molecular diagnostics market

Key Players in the molecular diagnostics market

Research Highlights

Globally, Molecular Diagnostics market is expected to reach US$ 15 Billion by 2014

Infectious disease testing dominates the molecular diagnostics market with more than

21% market share in 2010

Oncology and infectious disease testing sectors are likely growth leaders in the

molecular diagnostics market

Blood Screening & Genetic testing will have a combined market share of 26% by 2014

Biochips market is expected to cross US$ 3 Billion by 2014

Fish & Innovation testing is expected to capture more than 16% market share by 2014

USA is expected to have more than US$ 6 Billion molecular diagnostics market by 2014

© Renub Research Page 4 of 10

Key Players Analyzed

This section covers the key facts about the major players in molecular diagnostics market.

The key players analyzed in this section are Roche, Abbott, Bayer AG, Qiagen, Gen-Probe,

Becton Dickinson and Company, bioMérieux, Myriad Genetics, Inc., Celera Corporation.

Data Sources

Information and data in this report has been collected from various printable and non-

printable sources like Trade Journals, White papers, Online paid databases, News websites,

Government Agencies, Magazines, Newspapers and Trade associations.

© Renub Research Page 5 of 10

Table of Contents

1. Executive Summary

2. Global – Molecular Diagnostics Market & Market Shares (Application wise and Technological

wise)

2.1 Molecular Diagnostics Market & Future Forecast

2.2 Molecular Diagnostics Market Share & Future Forecast (Application Segment)

2.3 Molecular Diagnostics Market Share & Future Forecast (Technologies Segment)

3. Molecular Diagnostics Market (Application Segment) – 2008 to 2014

3.1 Infectious Disease Testing Market

3.1.1 Virology Testing Market

3.1.2 Haemagglutination-Inhibition Test (HAI) Testing

3.1.3 Critical Care Infectious Testing Market

3.2 Blood Screening Market

3.3 Genetic Testing Market

3.4 Oncology Testing Market

3.5 Tissue Typing (HLA Testing) Market

3.6 Cardiovascular Disease Testing Market

3.7 Neurological Disorders Testing Market

3.8 Food Pathogen Detection Testing Market

4. Molecular Diagnostics Market (Technologies Segment) – 2008 to 2014

4.1 PCR Based Test Market

4.2 PCR Related Technologies Market

4.3 Non-PCR Test Market

4.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization)

4.5 Biochips Market

4.6 Biosensors

4.7 Other Technologies Market

5. Geographical Distribution - Molecular Diagnostics Market (2008 to 2014)

© Renub Research Page 6 of 10

5.1 United States Molecular Diagnostics Market

5.2 Europe, the Middle East & Africa (EMEA) Molecular Diagnostics Market

5.3 Germany Molecular Diagnostics Market

5.4 India Molecular Diagnostics Market

5.5 China Molecular Diagnostics Market

5.6 Japan Molecular Diagnostics Market

5.7 Brazil Molecular Diagnostics Market

5.8 Mexico Molecular Diagnostics Market

5.9 South Korea Molecular Diagnostics Market

6. Global Mergers & Acquisitions Deals in the Molecular Diagnostics Sector

7. Key Drivers of Growth in Global Molecular Diagnostics Market

7.1 Aging of the population

7.2 Re-Emergence of infectious threats (drug resistant TB, new strains of HIV, H1N1 & other flu)

7.3 Scientific and Technological Advancements

8. Challenges

8.1 Reimbursement

8.2 The need for new Biomarker Assays

8.3 Regulatory Environment

8.4 Awareness and Acceptance

9. Key Players

9.1 Roche

9.2 Abbott Laboratories

9.3 Qiagen

9.4 BD (Becton, Dickinson and Company)

9.5 biomerieux

9.6 Bayer AG

9.7 Gen-Probe

9.8 Myriad Genetics, Inc

© Renub Research Page 7 of 10

9.9 Celera Corporation

9.10 Beckman Coulter

© Renub Research Page 8 of 10

Order Form

Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact

Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780

Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

info@renub.com

Format

Report Title: Global Molecular Diagnostics Market & Future Forecast 2010 - 2014

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1,200 US$ 1,300 US$ 1,300 US$ 1,800

For ordering this report: Three easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):

http://www.renub.com/report/global-molecular-diagnostics-market-future-forecast-2010---

2014-45

2) Order by Wire Transfer:

http://www.renub.com/report/wiretransfer.aspx?id=45&pid=1161

To pay by Wire Transfer, please, fill in your contact details in the form below:

© Renub Research Page 9 of 10

Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India

Contact Information

First Name: Last Name:

Email:

Job Title:

Company:

Address:

City:

Postal/Zip Code:

Country:

Phone:

Mobile:

Fax:

Report Format:

Your message:

© Renub Research Page 10 of 10

3) Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

1st Floor,

C-86, Sector -10

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us

Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090

LinkedIn: http://www.linkedin.com/company/renub-research

Twitter: http://twitter.com/RenubResearch